Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Matthews

Showing results (211-220 of 293) with videos related to

Pageof 30
Sort By:
Hepatology (Baltimore, Md.)|August 31, 2010
Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infectionJason Grebely, Kathy Petoumenos, Margaret Hellard, et al.
Antiviral Therapy|August 11, 2016
Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studiesMarianne Martinello, Margaret Hellard, David Shaw, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 24, 2020
Large transmission cluster of acute hepatitis C identified among HIV-positive men who have sex with men in Bangkok, ThailandWin M Han, Donn J Colby, Apichaya Khlaiphuengsin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2016
Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infectionDavid A Sheridan, Behzad Hajarizadeh, Fiona I Fenwick, et al.
Journal of Viral Hepatitis|November 25, 2016
A molecular transmission network of recent hepatitis C infection in people with and without HIV: Implications for targeted treatment strategiesSofia R Bartlett, Joel O Wertheim, Rowena A Bull, et al.
Antiviral Therapy|February 12, 2016
Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studiesMarianne Martinello, Margaret Hellard, David Shaw, et al.
The International Journal on Drug Policy|August 24, 2021
Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohortJoanne M Carson, Behzad Hajarizadeh, Josh Hanson, et al.
Hepatology (Baltimore, Md.)|October 10, 2018
Benefit of Early versus Deferred Antiretroviral Therapy on Progression of Liver Fibrosis among People with HIV in the START Randomized TrialNila J Dharan, Jacqueline Neuhaus, Juergen K Rockstroh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 9, 2021
Opportunities to Enhance Linkage to Hepatitis C Care Among Hospitalized People With Recent Drug Dependence in New South Wales, Australia: A Population-based Linkage StudyHeather Valerio, Maryam Alavi, Matthew Law, et al.
Open Forum Infectious Diseases|December 18, 2024
Control and Elimination of Hepatitis C Virus Among People With HIV in Australia: Extended Follow-up of the CEASE Cohort (2014-2023)Marianne Martinello, Joanne M Carson, Jeffrey J Post, et al.
Pageof 30

Showing results (211-220 of 293) with videos related to

Sort By:
Pageof 30
Hepatology (Baltimore, Md.)|August 31, 2010
Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infectionJason Grebely, Kathy Petoumenos, Margaret Hellard, et al.
Antiviral Therapy|August 11, 2016
Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studiesMarianne Martinello, Margaret Hellard, David Shaw, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 24, 2020
Large transmission cluster of acute hepatitis C identified among HIV-positive men who have sex with men in Bangkok, ThailandWin M Han, Donn J Colby, Apichaya Khlaiphuengsin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2016
Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infectionDavid A Sheridan, Behzad Hajarizadeh, Fiona I Fenwick, et al.
Journal of Viral Hepatitis|November 25, 2016
A molecular transmission network of recent hepatitis C infection in people with and without HIV: Implications for targeted treatment strategiesSofia R Bartlett, Joel O Wertheim, Rowena A Bull, et al.
Antiviral Therapy|February 12, 2016
Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studiesMarianne Martinello, Margaret Hellard, David Shaw, et al.
The International Journal on Drug Policy|August 24, 2021
Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohortJoanne M Carson, Behzad Hajarizadeh, Josh Hanson, et al.
Hepatology (Baltimore, Md.)|October 10, 2018
Benefit of Early versus Deferred Antiretroviral Therapy on Progression of Liver Fibrosis among People with HIV in the START Randomized TrialNila J Dharan, Jacqueline Neuhaus, Juergen K Rockstroh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 9, 2021
Opportunities to Enhance Linkage to Hepatitis C Care Among Hospitalized People With Recent Drug Dependence in New South Wales, Australia: A Population-based Linkage StudyHeather Valerio, Maryam Alavi, Matthew Law, et al.
Open Forum Infectious Diseases|December 18, 2024
Control and Elimination of Hepatitis C Virus Among People With HIV in Australia: Extended Follow-up of the CEASE Cohort (2014-2023)Marianne Martinello, Joanne M Carson, Jeffrey J Post, et al.
Pageof 30